Published in Glia on July 10, 2013
Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS. J Neurovirol (2014) 0.84
Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy. Cell Death Dis (2014) 0.83
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Sci Rep (2016) 0.79
Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol Psychiatry (2016) 0.79
Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα. Front Mol Neurosci (2017) 0.75
Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci (2017) 0.75
The role of heparan sulfate deficiency in autistic phenotype: potential involvement of Slit/Robo/srGAPs-mediated dendritic spine formation. Neural Dev (2016) 0.75
APP Causes Hyperexcitability in Fragile X Mice. Front Mol Neurosci (2016) 0.75
YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice. Front Aging Neurosci (2017) 0.75
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95
Neuroanatomy of autism. Trends Neurosci (2008) 5.59
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science (1997) 4.26
A clinicopathological study of autism. Brain (1998) 3.49
Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci (2000) 3.38
Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci (2005) 3.01
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A (1988) 2.95
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev (1997) 2.72
The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci (2002) 2.65
Minicolumnar abnormalities in autism. Acta Neuropathol (2006) 2.62
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol (2003) 2.57
The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci (2012) 2.53
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell (1995) 2.37
Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev (2004) 2.31
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron (1993) 2.29
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature (1997) 2.26
Cytokines and CNS development. Neuron (2009) 2.15
Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand (2000) 2.14
The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron (1992) 1.72
Delta-Notch signaling controls the generation of neurons/glia from neural stem cells in a stepwise process. Development (2003) 1.61
Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem (2001) 1.56
beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci (1993) 1.48
Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci (2000) 1.48
Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc Natl Acad Sci U S A (1994) 1.43
Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum (2005) 1.33
Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature (1996) 1.32
CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci (2011) 1.22
Notch signaling, brain development, and human disease. Pediatr Res (2005) 1.22
Cross talk between notch and growth factor/cytokine signaling pathways in neural stem cells. Mol Cell Biol (2007) 1.21
STAT3 signaling after traumatic brain injury. J Neurochem (2012) 1.19
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol (2006) 1.18
Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem (1994) 1.16
Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Res (1996) 1.14
Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia (1999) 1.12
Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev (2006) 1.12
Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist (2006) 1.12
Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J Neurol Sci (1990) 1.10
What's new in autism? Eur J Pediatr (2008) 1.07
Role of IL-6 in the neural stem cell differentiation. Clin Rev Allergy Immunol (2005) 1.03
Course of autism signs in the first year of life. Psychopathology (2005) 1.02
Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One (2011) 1.01
Up a notch: instructing gliogenesis. Neuron (2000) 1.01
sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol Cell Neurosci (2010) 1.00
Amyloid precursor protein is localized in growing neurites of neonatal rat brain. Brain Res (1992) 0.98
Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion. Glia (2010) 0.97
Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J Neurosci (2002) 0.97
Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann N Y Acad Sci (1996) 0.97
Secreted forms of the amyloid-beta precursor protein are ligands for the class A scavenger receptor. J Biol Chem (2001) 0.92
Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry (1993) 0.91
Induction of STAT3 signaling in activated astrocytes and sprouting septal neurons following entorhinal cortex lesion in adult rats. Mol Cell Neurosci (2002) 0.90
Secreted amyloid precursor proteins promote proliferation and glial differentiation of adult hippocampal neural progenitor cells. Hippocampus (2011) 0.90
Characterization of the neurotrophic interaction between nerve growth factor and secreted alpha-amyloid precursor protein. J Neurosci Res (2001) 0.87
Pathological and neuropathological findings in two males with fragile-X syndrome. J Intellect Disabil Res (2000) 0.87
Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor. J Neurochem (1995) 0.86
Interaction and imitation deficits from infancy to 4 years of age in children with autism: a pilot study based on videotapes. Autism (2005) 0.84
Practical issues in stem cell therapy for Alzheimer's disease. Curr Alzheimer Res (2007) 0.84
Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience (1998) 0.84
Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. Biochem Biophys Res Commun (2006) 0.82
Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-α: implications for autism. FASEB J (2011) 0.81
Involvement of notch signaling pathway in amyloid precursor protein induced glial differentiation. Eur J Pharmacol (2010) 0.79
Mechanism of glial differentiation of neural progenitor cells by amyloid precursor protein. Neurodegener Dis (2008) 0.79
Anterior insular cortex: linking intestinal pathology and brain function in autism-spectrum subgroups. Med Hypotheses (2001) 0.79
Activated Notch1 is a stronger astrocytic stimulus than leukemia inhibitory factor for rat neural stem cells. Int J Dev Biol (2009) 0.78
Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen. Biochim Biophys Acta (2002) 0.78
Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway. Neurotox Res (2010) 0.78
Roles of glial cells in neural circuit formation: insights from research in insects. Glia (2010) 0.78
[The role of the glycoprotein gp130 in serotonin mediator system in mouse brain]. Mol Biol (Mosk) (2010) 0.76
A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2002) 4.57
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry (2007) 3.39
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med (2008) 3.15
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J (2005) 2.30
The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation (2005) 2.23
Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med (2006) 2.11
Compositional gradients in Gramineae genes. Genome Res (2002) 2.04
Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol (2006) 2.00
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci (2005) 1.99
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 1.99
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat Neurosci (2002) 1.97
Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis (2009) 1.91
Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.91
Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol (2005) 1.90
Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx (2006) 1.82
Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis? Ann Thorac Surg (2002) 1.66
Microglia recognize double-stranded RNA via TLR3. J Immunol (2006) 1.60
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation (2005) 1.57
Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol (2009) 1.54
Strand transfer events during HIV-1 reverse transcription. Virus Res (2008) 1.51
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. J Gastroenterol Hepatol (2009) 1.50
Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg (2002) 1.48
Fabrication of Graphene/Polyaniline Composite Paper via In Situ Anodic Electropolymerization for High-Performance Flexible Electrode. ACS Nano (2009) 1.47
MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett (2011) 1.42
Applicability of blunt renal trauma classification of Japanese Association for the Surgery of Trauma (JAST). Int J Urol (2009) 1.41
T-cells in Alzheimer's disease. Neuromolecular Med (2005) 1.38
CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol (2005) 1.38
Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia (2004) 1.37
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res (2008) 1.35
Genome sequence of the date palm Phoenix dactylifera L. Nat Commun (2013) 1.35
Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma. Clin Cancer Res (2011) 1.35
Efficient calculation of configurational entropy from molecular simulations by combining the mutual-information expansion and nearest-neighbor methods. J Comput Chem (2008) 1.35
Ruptured hepatic abscess caused by fish bone penetration of the duodenal wall: report of a case. Surg Today (2007) 1.30
Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29
Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr (2007) 1.28
Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis (2002) 1.27
The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance. J Biomed Mater Res A (2007) 1.27
First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis (2013) 1.25
Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis (2010) 1.25
Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry (2005) 1.24
Separation of left and right lungs using 3-dimensional information of sequential computed tomography images and a guided dynamic programming algorithm. J Comput Assist Tomogr (2011) 1.24
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci (2011) 1.22
Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem (2007) 1.22
GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J Alzheimers Dis (2010) 1.22
A genome-wide microsatellite polymorphism database for the indica and japonica rice. DNA Res (2007) 1.21
Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angew Chem Int Ed Engl (2013) 1.21
CD40 is expressed and functional on neuronal cells. EMBO J (2002) 1.19
Inhibition of angiogenesis by Abeta peptides. Angiogenesis (2004) 1.19
A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg (2003) 1.18
ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem (2006) 1.17
Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem (2012) 1.17
Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures. Adv Mater (2012) 1.16
High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv Mater (2013) 1.16
Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. J Alzheimers Dis (2010) 1.16
Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia (2010) 1.15
Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). J Neuroimmunol (2002) 1.13
Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst (2003) 1.13
Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells. Nanotechnology (2006) 1.13
Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Adv Mater (2013) 1.13
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry (2013) 1.11
Protection against ischemic brain injury by protein therapeutics. Proc Natl Acad Sci U S A (2002) 1.11
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis (2009) 1.10
HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res (2012) 1.09
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain (2011) 1.08
Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev (2008) 1.08
Alternative splicing of Slo channel gene programmed by estrogen, progesterone and pregnancy. FEBS Lett (2005) 1.08
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol Biol (2012) 1.08
S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors. PLoS One (2011) 1.07
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation. Nat Commun (2012) 1.07
Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey. Child Psychiatry Hum Dev (2011) 1.06
Modulation of alpha and beta crystallin expression in rat retinas with ocular hypertension-induced ganglion cell degeneration. Brain Res (2007) 1.06
Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry (2002) 1.06